Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Enhertu for HER2-low or HER2-ultralow metastatic breast cancer Enhertu (trastuzumab deruxtecan) is making waves in breast cancer treatment
Int J Clin Exp Med 8(8):1200912017 Caiado F, Manz MG (2025) Gut microbiota fuels clonal hematopoiesis
The FDA-approved branded versions like Wegovy and Zepbound carry list prices exceeding $900 per month before insurance negotiations
Check back for more stories about the lesser-known downsides of these wildly popular medications
Limit sugar and dairy intake , as both can influence hormonal activity
US$ 27.45
US$ 27.92
US$ 29.77
US$ 22.85
US$ 23.58
US$ 27.28
